S100A9 and glioblastoma: In GBM, we found that in the high expression group of S100A9, the immune score (Supplementary Figure 1A) and stromal score (Supplementary Figure 1B) were significantly higher than those in the low expression group, which prompted us to conduct further analysis and research.